Tech Company Financing Transactions
Synthesize Bio Funding Round
Madrona Venture Group, AI2 Incubator and Inner Loop Capital participated in a $10 million Seed capital raise for Synthesize Bio. This venture round was announced on 9/17/2025.
Transaction Overview
Company Name
Announced On
9/17/2025
Transaction Type
Venture Equity
Amount
$10,000,000
Round
Seed
Investors
Proceeds Purpose
The company intends to use the funds to accelerate the development of its generative genomics models and expand access for biopharmaceutical companies and researchers.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
Seattle, WA Undisclosed
USA
Seattle, WA Undisclosed
USA
Phone
Undisclosed
Website
Email Address
Overview
Synthesize Bio develops generative AI models that accelerate biomedical innovation. Our generative genomics platform is a new paradigm for drug development that redefines what's possible. GEM-1, our flagship foundation model, generates high-fidelity bulk and single-cell RNA-seq data from experimental descriptions with lab-level accuracy. We empower researchers to test hypotheses and answer biological questions with unprecedented speed, especially when experimental data is limited.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Co-Founder
Rob Bradley
Co-Founder
Jeff Leek
Browse more venture capital transactions:
Prev: 9/17/2025: Upscale AI venture capital transaction
Next: 9/17/2025: BIO Protocol venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on all VC transactions involving tech companies. VC investment data records reported here come from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs